NCT00054262View on ClinicalTrials.gov

T900607 in Treating Patients With Unresectable Liver Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2002

Primary Completion Date

March 31, 2004

Study Completion Date

September 30, 2010

Conditions
Liver Cancer
Interventions
DRUG

T900607

Trial Locations (1)

44106-1714

Ireland Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University Hospitals Seidman Cancer Center

OTHER

NCT00054262 - T900607 in Treating Patients With Unresectable Liver Cancer | Biotech Hunter | Biotech Hunter